[go: up one dir, main page]

CL2014000059A1 - Compounds derived from substituted nitrogen heterocycles; Preparation process; intermediate compound; pharmaceutical compositions; Useful as inhibitors of hcv replication to treat hepatitis c. (div. sun. 970-13) - Google Patents

Compounds derived from substituted nitrogen heterocycles; Preparation process; intermediate compound; pharmaceutical compositions; Useful as inhibitors of hcv replication to treat hepatitis c. (div. sun. 970-13)

Info

Publication number
CL2014000059A1
CL2014000059A1 CL2014000059A CL2014000059A CL2014000059A1 CL 2014000059 A1 CL2014000059 A1 CL 2014000059A1 CL 2014000059 A CL2014000059 A CL 2014000059A CL 2014000059 A CL2014000059 A CL 2014000059A CL 2014000059 A1 CL2014000059 A1 CL 2014000059A1
Authority
CL
Chile
Prior art keywords
div
sun
inhibitors
useful
pharmaceutical compositions
Prior art date
Application number
CL2014000059A
Other languages
Spanish (es)
Inventor
Charles W Hutchins
Pamela L Donner
Allan C Krueger
Lissa T Nelson
Sachel V Patel
Mark A Matulenko
Tammie K Jinkerson
Yi Gao
John K Pratt
Todd W Rockway
Clarence J Maring
Douglas K Hutchinson
Charles A Flentge
Rolf Wagner
Michael D Tufano
David A Betebenner
Kathy Sarris
Kevin R Woller
Sebel H Wagaw
Jean C Califano
Wenke Li
Dachun Liu
David A Degoey
Warren M Kati
John T Randolph
Christopher E Motter
Ryan G Keddy
Daniel D Caspi
Mary E Bellizzi
William A Carroll
Original Assignee
Abbvie Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/903,822 external-priority patent/US20110092415A1/en
Application filed by Abbvie Inc filed Critical Abbvie Inc
Publication of CL2014000059A1 publication Critical patent/CL2014000059A1/en

Links

CL2014000059A 2010-10-13 2014-01-09 Compounds derived from substituted nitrogen heterocycles; Preparation process; intermediate compound; pharmaceutical compositions; Useful as inhibitors of hcv replication to treat hepatitis c. (div. sun. 970-13) CL2014000059A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12/903,822 US20110092415A1 (en) 2009-06-11 2010-10-13 Anti-Viral Compounds
US12/964,027 US8921514B2 (en) 2009-06-11 2010-12-09 Anti-viral compounds
US201161446800P 2011-02-25 2011-02-25

Publications (1)

Publication Number Publication Date
CL2014000059A1 true CL2014000059A1 (en) 2014-09-05

Family

ID=49085262

Family Applications (2)

Application Number Title Priority Date Filing Date
CL2013000970A CL2013000970A1 (en) 2010-10-13 2013-04-10 Compounds derived from substituted nitrogen heterocycles; its pharmaceutical compositions, and use as inhibitors of hcv replication for the treatment of hepatitis c.
CL2014000059A CL2014000059A1 (en) 2010-10-13 2014-01-09 Compounds derived from substituted nitrogen heterocycles; Preparation process; intermediate compound; pharmaceutical compositions; Useful as inhibitors of hcv replication to treat hepatitis c. (div. sun. 970-13)

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CL2013000970A CL2013000970A1 (en) 2010-10-13 2013-04-10 Compounds derived from substituted nitrogen heterocycles; its pharmaceutical compositions, and use as inhibitors of hcv replication for the treatment of hepatitis c.

Country Status (2)

Country Link
CL (2) CL2013000970A1 (en)
CR (2) CR20130170A (en)

Also Published As

Publication number Publication date
CR20130170A (en) 2013-08-07
CL2013000970A1 (en) 2013-09-06
CR20140021A (en) 2014-03-12

Similar Documents

Publication Publication Date Title
PH12020550552A1 (en) Inhibitors of hepatitis c virus
UA116083C2 (en) PURINE DERIVATIVES FOR TREATMENT OF VIRAL INFECTIONS
UA113651C2 (en) MACROCYCLIC PURINS FOR TREATMENT OF Viral INFECTIONS
EP2667714A4 (en) PROCESS FOR THE PREPARATION OF 4-AMINO-5-FLUORO-3-HALOGENO-6- (SUBSTITUTED) PICOLINATES
EA201591527A1 (en) NEW PYRIDINE DERIVATIVES
CY1116987T1 (en) Concentrated imidazolylimidazoles as antiviral compounds
BR112012017402A2 (en) flaviviridae virus inhibitors
EP2687510A4 (en) PROCESS FOR THE PREPARATION OF 2,3-DICHLOROPYRIDINE
IN2014MN02652A (en)
UA113956C2 (en) PIRIMIDIN DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS
EA201590931A1 (en) HETEROCYCLIC SUBSTITUTED DERIVATIVES 2-AMINO-HINAZOLINE FOR THE TREATMENT OF VIRAL INFECTIONS
PH12013501543A1 (en) Hepatitis c virus inhibitors
EA201892050A1 (en) METHOD OF OBTAINING SUBSTITUTED 5-FLUOR-1H-PYRAZOLOPIRIDINES
BR112014009114A2 (en) compounds, pharmaceutical compositions, treatment methods, uses of a compound and polymorph preparation process
IN2014CN04530A (en)
MX347692B (en) HEPATITIS VIRUS INHIBITORS C.
MY186547A (en) 4?-fluoro-2?-methyl substituted nucleoside derivatives
BR112013004662B8 (en) Compound, pharmaceutical composition, uses of a compound, and method of preparing a pharmaceutical composition
PH12013502177A1 (en) Hepatitis c virus inhibitors
EP2738153A4 (en) PROCESS FOR THE PREPARATION OF 3,3-DIMETHYLBUTYRALDEHYDE
SMT201700028B (en) BENZOFURANIC COMPOUNDS FOR THE TREATMENT OF HEPATITIS C VIRUS INFECTIONS
DK2939665T3 (en) PHARMACEUTICAL COMPOSITION FOR TREATMENT OF HIV INFECTIONS
MY164880A (en) Process for the preparation of isoxazolyl-methoxy-nicotinic acids
SG194711A1 (en) Processes for preparing inhibitors of the hepatitis c virus
EP2634182A4 (en) PROCESS FOR THE PREPARATION OF 1,3,5-TRIOXANE